scorecardresearch
Add as a preferred source on Google
Tuesday, April 7, 2026
TopicUzbekistan

Topic: Uzbekistan

Firm wouldn’t exist without you—HC snub to Marion Biotech directors in Uzbekistan cough syrup deaths

Marion Biotech is the Noida-based manufacturer of DOK-I Max cough syrup, which was linked to the deaths of at least 18 children in Uzbekistan in 2022.

Uzbekistan plans to add India to visa-free list, treble number of Indian visitors by 2030

The effort is part of the country's 2030 national development vision. In 2024, 72,300 Indian nationals visited Uzbekistan.

ADB approves $300 million for ‘inclusive finance’ in Uzbekistan

The loan aims to boost microfinance sector, support small businesses and women entrepreneurs.

India permits reopening of cough syrup firm linked to children’s deaths in Uzbekistan

The Marion factory in Uttar Pradesh was closed in March, after an analysis last year by Uzbekistan's health ministry of two cough syrups made by Marion, Ambronol and DOK-1 Max.

Uzbekistan says distributors of contaminated Indian cough syrup paid bribe to skip testing

The country put 21 people on trial - 20 of whom are Uzbeks and one Indian - over the deaths last week, making public for the first time a much higher death toll than previously reported.

Noida pharma company linked to Uzbekistan deaths halts cough syrup production, says report

Drug maker Marion Biotech said it regretted the deaths and informed about the govt conducting an enquiry. 'We'll take action as per report,' the company's legal representative said.

I visited the land of Babur and Timur, Uzbekistan’s ‘national hero’

In Uzbekistan to cover the Shanghai Cooperation Organisation summit, I saw the land of Timur whom Indian history books will always remember as the 'plunderer' of Delhi.

‘Will support India in doing good job’ — Xi’s trip to Samarkand had a clear message

The SCO summit was Xi Jinping’s first foreign trip after the pandemic. It showed China’s Eurasian dream.

Forgotten story of great Hindu merchants in Central Asia shows enterprise can defeat China

The fortunes Indian merchants built in Samarkand, Bukhara and Tashkent were based on a single, simple thing: Selling all that Central Asian consumers needed.

On Camera

Syringes, MRI to ventilators, West Asia war squeezing India’s medical supply chain—costs up 10 to 50%

Industry says manufacturers have 2-4 weeks of buffer stocks, but prolonged disruption could push up shortage risks, especially of consumables like IV and syringes.

UAE walks away from financing Rafale F5 due to restricted access to technology, reports French media

French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.